Équilibre Biopharmaceuticals
Ms. Younis, Vice President Regulatory affairs at Equilibre Biopharmaceuticals and PhD candidate in Vaccinology/Immunology, is a seasoned professional with a strong background in regulatory affairs, clinical research, product development, and quality assurance. As a former regulatory affairs and CMC professional at Janssen Vaccines & Prevention - Johnson & Johnson, she provided regulatory strategy and advice for IND, IMPD, Marketing Authorization Applications globally and Emergency Use Authorization applications. The licenses were submitted and granted for several prophylactic vaccines and therapeutic drugs.
Ms. Younis holds a MSc in Biomedical Sciences, Immunology and Infectious Diseases from the Vrije Universiteit Amsterdam and a B.AS in Life Sciences-Biomedical Sciences from Hogeschool Rotterdam.
This person is not in any offices
Équilibre Biopharmaceuticals
Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications.